Marie Boutaud

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Cell Cycle Arrest

Chronic Lymphocytic Leukemia

Top Venues

Cancer gene therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Léa Ikhlef, Nina Ratti, Stéphanie Durand, Rémy Formento, Héloïse Daverat, Marie Boutaud, Clément Guillou, Natalya Dmytruk, Nathalie Gachard, Pascal Cosette, Marie-Odile Jauberteau, Paul-François Gallet
Extracellular vesicles from type-2 macrophages increase the survival of chronic lymphocytic leukemia cells ex vivo. Cancer gene therapy 31 (8) (2024)
Léa Ikhlef, Nina Ratti, Stéphanie Durand, Rémy Formento, Héloïse Daverat, Marie Boutaud, Clément Guillou, Natalya Dmytruk, Nathalie Gachard, Pascal Cosette, Marie-Odile Jauberteau, Paul-François Gallet
Extracellular vesicles from type-2 macrophages increase the survival of chronic lymphocytic leukemia cells ex vivo. Cancer gene therapy 31 (8) (2024)
Léa Ikhlef, Nina Ratti, Stéphanie Durand, Rémy Formento, Héloïse Daverat, Marie Boutaud, Clément Guillou, Natalya Dmytruk, Nathalie Gachard, Pascal Cosette, Marie-Odile Jauberteau, Paul-François Gallet
Extracellular vesicles from type-2 macrophages increase the survival of chronic lymphocytic leukemia cells ex vivo. Cancer gene therapy 31 (8) (2024)
Léa Ikhlef, Nina Ratti, Stéphanie Durand, Rémy Formento, Héloïse Daverat, Marie Boutaud, Clément Guillou, Natalya Dmytruk, Nathalie Gachard, Pascal Cosette, Marie-Odile Jauberteau, Paul-François Gallet
Extracellular vesicles from type-2 macrophages increase the survival of chronic lymphocytic leukemia cells ex vivo. Cancer gene therapy (2024)
Marie Boutaud, Clément Auger, Mireille Verdier, Niki Christou
Metformin Treatment Reduces CRC Aggressiveness in a Glucose-Independent Manner: An In Vitro and Ex Vivo Study. Cancers 15 (14) (2023)